Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I'm a bit surprised

Even if we get a "win" at this ITC Ruling, which I personally doubt, there are still a whole host of very serious obsticles to overcome; not the least of which is a complete absence of TRUST and competency in PTSC's leadership to translate these legal developments and future MMP licensing fees into a legitimate rise in the Stock price.

This is the main problem that PTSC Shareholders need to find a way to address and eliminate if they want enough new investor demand to be able to absorb selling shares at higher prices.

Unless we find a way to create a change in the perception of potential investors, be prepared to hold your PTSC stock until the very last penny of MMP licensing is received by PTSC, and hopefully paid out to Stockholders as a dividend.

Share
New Message
Please login to post a reply